Kohla Samah A, Sabbagh Ahmad Al, Omri Halima El, Ibrahim Firyal A, Otazu Ivone B, Alhajri Hessa, Yassin Mohamed A
Department of Laboratory Medicine and Pathology, Hematopathology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Haematology and Medical Oncology, Hamad Medical Corporation, Doha, Qatar.
Clin Med Insights Blood Disord. 2015 Sep 21;8:25-31. doi: 10.4137/CMBD.S24631. eCollection 2015.
Mixed phenotype acute leukemia (MPAL) is considered as a rare type of leukemia with an incidence of less than 4% of all acute leukemia based on the most recent 2008 WHO classification. Common subtypes are the B/myeloid and T/myeloid; B/T and trilineage MPAL being extremely rare. We present a case of a male in his 20s, whose peripheral blood smears showed 34% blast cells and bone marrow with 70% blasts. Immunophenotyping by multiparametric flow cytometry showed two populations of blasts, the major one with B-lineage and the minor one with T-lineage. Conventional karyotyping revealed complex karyotype with the presence of double Philadelphia chromosome (Ph (+)). BCR/ABL1 rearrangement was confirmed by fluorescent in situ hybridization (FISH) analysis. The BCR/ABL1 ES probe on interphase cells indicated p190 minor m-BCR/ABL fusion in 46% and a second abnormal clone with double Ph (+) in 16% of the cells analyzed confirmed by reverse transcription-PCR (RT-PCR). The case was diagnosed as MPAL with double Philadelphia chromosome Ph (+). The patient was treated with dasatinib, four cycle hyper CVAD/methotrexate cytarabin protocol, and allogeneic transplant. He is still alive in complete hematological, cytogenetic, and molecular remission. Mixed phenotype B/T acute leukemia is an extremely rare disease, particularly those with double Philadelphia chromosomes and clinically presents challenges in diagnosis and treatment.
混合表型急性白血病(MPAL)被认为是一种罕见的白血病类型,根据2008年世界卫生组织的最新分类,其发病率不到所有急性白血病的4%。常见亚型为B/髓系和T/髓系;B/T和三系MPAL极为罕见。我们报告一例20多岁男性病例,其外周血涂片显示34%的原始细胞,骨髓中原始细胞占70%。通过多参数流式细胞术进行免疫表型分析显示有两个原始细胞群,主要群体为B系,次要群体为T系。常规核型分析显示为复杂核型,存在双费城染色体(Ph(+))。荧光原位杂交(FISH)分析证实了BCR/ABL1重排。间期细胞上的BCR/ABL1 ES探针显示46%的细胞中有p190微小m-BCR/ABL融合,通过逆转录聚合酶链反应(RT-PCR)证实,在16%的分析细胞中有第二个双Ph(+)异常克隆。该病例被诊断为伴有双费城染色体Ph(+)的MPAL。患者接受了达沙替尼、四个周期的hyper CVAD/甲氨蝶呤阿糖胞苷方案以及异基因移植治疗。他目前仍存活,处于完全血液学、细胞遗传学和分子学缓解状态。混合表型B/T急性白血病是一种极其罕见的疾病,尤其是那些伴有双费城染色体的病例,在临床诊断和治疗方面存在挑战。